ADVERTISEMENT
Using Patient-Reported Measures in Value-Based Payment Models to Promote Patient-Centered Cancer Care
In April 2021, researchers at the National Pharmaceutical Council and Discern Health published an article in the Journal of Clinical Pathways that offers recommendations to the Biden administration to make cancer care more patient-centered (2021;7[3]:60-63. doi:10.25270/jcp.2021.04.00002).
In this video, Theresa Schmidt, MA, Vice President, Discern Health, and Kimberly Westrich, MA, Vice President of Health Services Research, National Pharmaceutical Council, discuss the role of patient-reported measures in value-based payment models to promote patient-centered cancer care.
Related Resources:
Blog: Patient Voices in Value-Based Cancer Care: Priorities for the Biden Administration
Disclaimer: The views and opinions expressed are those of the author(s) and do not necessarily reflect the official policy or position of Journal of Clinical Pathways or HMP Global, their employees, and affiliates. Any content provided by our bloggers or authors are of their opinion and are not intended to malign any religion, ethnic group, club, association, organization, company, individual, anyone, or anything.
